Study on medicinal chemistry of k203 in wistar rats and beagle dogs

H. Kalász, P. Szegi, G. Jánoki, L. Balogh, Z. Pöstényi, K. Musilek, G. A. Petroianu, A. Siddiq, K. Tekes

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

K203 is an experimental bis-pyridinium mono-aldoxime type cholinesterase reactivator of potential use in organophosphate/ organophosphonate poisoning. Pharmacokinetics of K203 were examined in Wistar rats and beagle dogs using ion-pair HPLC. Serum and cerebrospinal fluid concentrations of K203 were determined using ion-pair reversedphase chromatography on octadecyl silica column. HPLC with ultraviolet detection was used for determination of serum concentration of K203 higher than 0.1 μg/mL while its low concentrations in cerebrospinal fluid required electrochemical detection (0.015 through 4 μg/mL range). In rats the serum levels of K203 followed zero order pharmacokinetics from 15 to 120 minutes post administration. Zero order pharmacokinetics was also observed in beagle dogs after low dose (15 μmol/kg) of K203 administration. High dose administration (250 ?mol/kg) led to subsequent hindered elimination from both cerebrospinal fluid and serum.

Original languageEnglish
Pages (from-to)2137-2144
Number of pages8
JournalCurrent Medicinal Chemistry
Volume20
Issue number16
DOIs
Publication statusPublished - May 2013

Fingerprint

Cerebrospinal fluid
Pharmacokinetics
Pharmaceutical Chemistry
Wistar Rats
Rats
Dogs
Cerebrospinal Fluid
Cholinesterase Reactivators
Serum
Ions
Organophosphonates
Organophosphates
High Pressure Liquid Chromatography
Organophosphate Poisoning
Chromatography
Silicon Dioxide

Keywords

  • Amperometric detection
  • Beagle dogs
  • HPLC
  • K203
  • Pharmacokinetics
  • Rats
  • Serum level
  • UV detection

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Study on medicinal chemistry of k203 in wistar rats and beagle dogs. / Kalász, H.; Szegi, P.; Jánoki, G.; Balogh, L.; Pöstényi, Z.; Musilek, K.; Petroianu, G. A.; Siddiq, A.; Tekes, K.

In: Current Medicinal Chemistry, Vol. 20, No. 16, 05.2013, p. 2137-2144.

Research output: Contribution to journalArticle

Kalász, H, Szegi, P, Jánoki, G, Balogh, L, Pöstényi, Z, Musilek, K, Petroianu, GA, Siddiq, A & Tekes, K 2013, 'Study on medicinal chemistry of k203 in wistar rats and beagle dogs', Current Medicinal Chemistry, vol. 20, no. 16, pp. 2137-2144. https://doi.org/10.2174/0929867311320160006
Kalász, H. ; Szegi, P. ; Jánoki, G. ; Balogh, L. ; Pöstényi, Z. ; Musilek, K. ; Petroianu, G. A. ; Siddiq, A. ; Tekes, K. / Study on medicinal chemistry of k203 in wistar rats and beagle dogs. In: Current Medicinal Chemistry. 2013 ; Vol. 20, No. 16. pp. 2137-2144.
@article{fd89e700833b472485159b9d8d0333fe,
title = "Study on medicinal chemistry of k203 in wistar rats and beagle dogs",
abstract = "K203 is an experimental bis-pyridinium mono-aldoxime type cholinesterase reactivator of potential use in organophosphate/ organophosphonate poisoning. Pharmacokinetics of K203 were examined in Wistar rats and beagle dogs using ion-pair HPLC. Serum and cerebrospinal fluid concentrations of K203 were determined using ion-pair reversedphase chromatography on octadecyl silica column. HPLC with ultraviolet detection was used for determination of serum concentration of K203 higher than 0.1 μg/mL while its low concentrations in cerebrospinal fluid required electrochemical detection (0.015 through 4 μg/mL range). In rats the serum levels of K203 followed zero order pharmacokinetics from 15 to 120 minutes post administration. Zero order pharmacokinetics was also observed in beagle dogs after low dose (15 μmol/kg) of K203 administration. High dose administration (250 ?mol/kg) led to subsequent hindered elimination from both cerebrospinal fluid and serum.",
keywords = "Amperometric detection, Beagle dogs, HPLC, K203, Pharmacokinetics, Rats, Serum level, UV detection",
author = "H. Kal{\'a}sz and P. Szegi and G. J{\'a}noki and L. Balogh and Z. P{\"o}st{\'e}nyi and K. Musilek and Petroianu, {G. A.} and A. Siddiq and K. Tekes",
year = "2013",
month = "5",
doi = "10.2174/0929867311320160006",
language = "English",
volume = "20",
pages = "2137--2144",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "16",

}

TY - JOUR

T1 - Study on medicinal chemistry of k203 in wistar rats and beagle dogs

AU - Kalász, H.

AU - Szegi, P.

AU - Jánoki, G.

AU - Balogh, L.

AU - Pöstényi, Z.

AU - Musilek, K.

AU - Petroianu, G. A.

AU - Siddiq, A.

AU - Tekes, K.

PY - 2013/5

Y1 - 2013/5

N2 - K203 is an experimental bis-pyridinium mono-aldoxime type cholinesterase reactivator of potential use in organophosphate/ organophosphonate poisoning. Pharmacokinetics of K203 were examined in Wistar rats and beagle dogs using ion-pair HPLC. Serum and cerebrospinal fluid concentrations of K203 were determined using ion-pair reversedphase chromatography on octadecyl silica column. HPLC with ultraviolet detection was used for determination of serum concentration of K203 higher than 0.1 μg/mL while its low concentrations in cerebrospinal fluid required electrochemical detection (0.015 through 4 μg/mL range). In rats the serum levels of K203 followed zero order pharmacokinetics from 15 to 120 minutes post administration. Zero order pharmacokinetics was also observed in beagle dogs after low dose (15 μmol/kg) of K203 administration. High dose administration (250 ?mol/kg) led to subsequent hindered elimination from both cerebrospinal fluid and serum.

AB - K203 is an experimental bis-pyridinium mono-aldoxime type cholinesterase reactivator of potential use in organophosphate/ organophosphonate poisoning. Pharmacokinetics of K203 were examined in Wistar rats and beagle dogs using ion-pair HPLC. Serum and cerebrospinal fluid concentrations of K203 were determined using ion-pair reversedphase chromatography on octadecyl silica column. HPLC with ultraviolet detection was used for determination of serum concentration of K203 higher than 0.1 μg/mL while its low concentrations in cerebrospinal fluid required electrochemical detection (0.015 through 4 μg/mL range). In rats the serum levels of K203 followed zero order pharmacokinetics from 15 to 120 minutes post administration. Zero order pharmacokinetics was also observed in beagle dogs after low dose (15 μmol/kg) of K203 administration. High dose administration (250 ?mol/kg) led to subsequent hindered elimination from both cerebrospinal fluid and serum.

KW - Amperometric detection

KW - Beagle dogs

KW - HPLC

KW - K203

KW - Pharmacokinetics

KW - Rats

KW - Serum level

KW - UV detection

UR - http://www.scopus.com/inward/record.url?scp=84877950433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877950433&partnerID=8YFLogxK

U2 - 10.2174/0929867311320160006

DO - 10.2174/0929867311320160006

M3 - Article

VL - 20

SP - 2137

EP - 2144

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 16

ER -